Debora de Jong

2.9k total citations · 1 hit paper
52 papers, 2.3k citations indexed

About

Debora de Jong is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Debora de Jong has authored 52 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Cancer Research and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Debora de Jong's work include Cancer-related molecular mechanisms research (17 papers), Lymphoma Diagnosis and Treatment (17 papers) and RNA Research and Splicing (14 papers). Debora de Jong is often cited by papers focused on Cancer-related molecular mechanisms research (17 papers), Lymphoma Diagnosis and Treatment (17 papers) and RNA Research and Splicing (14 papers). Debora de Jong collaborates with scholars based in Netherlands, Poland and China. Debora de Jong's co-authors include Anke van den Berg, Sibrand Poppema, Joost Kluiver, Bart‐Jan Kroesen, Tjasso Blokzijl, S. Jacobs, Geert Harms, Arjan Diepstra, Klaas Kok and Miriam Hulsbeek and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Debora de Jong

51 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

2005 548 citations Joost Kluiver, Sibrand Poppema et al. The Journal of Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debora de Jong Netherlands	24	1.5k	1.4k	397	396	294	52	2.3k
Daoud Sie Netherlands	26	1.6k 1.0×	1.2k 0.8×	451 1.1×	161 0.4×	374 1.3×	55	2.6k
Lucy Stebbings United Kingdom	10	1.3k 0.8×	777 0.5×	468 1.2×	211 0.5×	163 0.6×	13	2.0k
Marc R. Mansour United Kingdom	26	1.9k 1.3×	347 0.2×	557 1.4×	191 0.5×	316 1.1×	59	2.9k
Monika Jung Germany	32	2.5k 1.6×	2.1k 1.5×	410 1.0×	99 0.3×	131 0.4×	51	3.3k
Bernat Gel Spain	22	1.6k 1.0×	965 0.7×	319 0.8×	218 0.6×	152 0.5×	48	2.4k
Ryan K. van Laar United States	18	1.1k 0.7×	410 0.3×	821 2.1×	508 1.3×	225 0.8×	34	2.1k
Xingzhi Song United States	15	1.2k 0.8×	470 0.3×	345 0.9×	110 0.3×	135 0.5×	44	2.0k
Mark T.A. Donoghue United States	23	1.8k 1.2×	914 0.6×	568 1.4×	120 0.3×	127 0.4×	58	3.1k
Robert Piskol United States	19	2.3k 1.5×	523 0.4×	711 1.8×	170 0.4×	499 1.7×	32	3.0k
Luciano G. Martelotto United States	25	776 0.5×	487 0.3×	449 1.1×	246 0.6×	105 0.4×	62	1.7k

Countries citing papers authored by Debora de Jong

Since Specialization

Citations

This map shows the geographic impact of Debora de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debora de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debora de Jong more than expected).

Fields of papers citing papers by Debora de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debora de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debora de Jong. The network helps show where Debora de Jong may publish in the future.

Co-authorship network of co-authors of Debora de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Debora de Jong. A scholar is included among the top collaborators of Debora de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debora de Jong. Debora de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yichen, Özlem Önder, Anagh A. Sahasrabuddhe, et al.. (2025). Palmitoylation by ZDHHC family members regulate B-cell lymphoma growth. International Journal of Biological Macromolecules. 320(Pt 2). 145876–145876. 1 indexed citations

Broeder, Nathan den, Debora de Jong, Marjolijn Duijvestein, et al.. (2024). OP15 High-definition white light endoscopy with segmental re-inspection is non-inferior compared to dye-based chromoendoscopy in Inflammatory Bowel Disease: the randomized controlled HELIOS trial. Journal of Crohn s and Colitis. 18(Supplement_1). i29–i30. 4 indexed citations

Liu, Yichen, Xing Zhao, Reyhaneh Ravanbakhsh Gavgani, et al.. (2024). Circular ZDHHC11 supports Burkitt lymphoma growth independent of its miR-150 binding capacity. Scientific Reports. 14(1). 8730–8730. 2 indexed citations

Zhao, Xing, Anke van den Berg, Melanie Winkle, et al.. (2023). Proliferation-promoting roles of linear and circular PVT1 are independent of their ability to bind miRNAs in B-cell lymphoma. International Journal of Biological Macromolecules. 253(Pt 2). 126744–126744. 6 indexed citations

Liu, Yichen, Debora de Jong, Jasper Koerts, et al.. (2022). The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma. Genes. 13(2). 227–227. 7 indexed citations

Dzikiewicz‐Krawczyk, Agnieszka, Arjan Diepstra, Bea Rutgers, et al.. (2018). Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells. American Journal Of Pathology. 188(5). 1289–1299. 6 indexed citations

Yuan, Ye, Ilja M. Nolte, Jasper Koerts, et al.. (2018). MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma. Cellular Physiology and Biochemistry. 49(1). 144–159. 24 indexed citations

Yuan, Ye, Joost Kluiver, Jasper Koerts, et al.. (2017). miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis. American Journal Of Pathology. 187(6). 1343–1355. 46 indexed citations

Diepstra, Arjan, Debora de Jong, Jasper Koerts, et al.. (2016). MUTATIONS IN CD58 AND MYB IN HODGKIN LYMPHOMA. Haematologica. 101. 4–5. 1 indexed citations

10.

Ślęzak-Prochazka, Izabella, Joost Kluiver, Debora de Jong, et al.. (2013). Cellular Localization and Processing of Primary Transcripts of Exonic MicroRNAs. PLoS ONE. 8(9). e76647–e76647. 22 indexed citations

11.

Gibcus, Johan H., Bart‐Jan Kroesen, Roelof Koster, et al.. (2011). MiR‐17/106b seed family regulates p21 in Hodgkin's lymphoma. The Journal of Pathology. 225(4). 609–617. 32 indexed citations

12.

Duns, Gerben, Debora de Jong, Ody C.M. Sibon, et al.. (2009). A high throughput experimental approach to identify miRNA targets in human cells. Nucleic Acids Research. 37(20). e137–e137. 92 indexed citations

13.

Bosga-Bouwer, Anneke, Anke van den Berg, Eugenia Haralambieva, et al.. (2006). Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?. Human Pathology. 37(5). 528–533. 45 indexed citations

14.

Kluiver, Joost, Anke van den Berg, Debora de Jong, et al.. (2006). Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene. 26(26). 3769–3776. 114 indexed citations

15.

Kluiver, Joost, Sibrand Poppema, Debora de Jong, et al.. (2005). BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. The Journal of Pathology. 207(2). 243–249. 548 indexed citations breakdown →

16.

Berg, Anke van den, Bart‐Jan Kroesen, Klaas Kooistra, et al.. (2003). High expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes and Cancer. 37(1). 20–28. 191 indexed citations

17.

Berg, Anke van den, R. Y. J. Tamminga, Debora de Jong, et al.. (2003). FAS Gene Mutation in a Case of Autoimmune Lymphoproliferative Syndrome Type IA With Accumulation of γδ+ T Cells. The American Journal of Surgical Pathology. 27(4). 546–553. 7 indexed citations

18.

Krámer, M, Jos Hermans, Jefferson Parker, et al.. (1996). Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma. Journal of Clinical Oncology. 14(7). 1 indexed citations

19.

Berg, Anke van den, Miriam Hulsbeek, Debora de Jong, et al.. (1996). Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosomes and Cancer. 15(1). 64–72. 56 indexed citations

20.

Chang, Andy, et al.. (1995). A novel human cDNA highly homologous to the fish hormone stanniocalcin. Molecular and Cellular Endocrinology. 112(2). 241–247. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact